1 |
Upmalis DH, Lobo R, Bradley L, et al (2000). Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women, A multicenter, double-blind, randomized, placebo-controlled study. Menopause, 7, 236-242.
DOI
|
2 |
Van Patten CL, Olivotto IA, Chambers GK, et al (2002). Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer, A randomized, controlled clinical trial. J Clin Oncol, 20, 1449-1455.
DOI
|
3 |
Washburn S, Burke GL, Morgan T, Anthony M (1999). Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause, 6, 7-13.
|
4 |
Weber L, Thacker HL (2014). Paroxetine, A first for selective serotonin reuptake inhibitors - a new use, Approved for vasomotor symptoms in postmenopausal women. Women's Health, 10, 147-54.
DOI
|
5 |
Wong VC, Lim CE, Luo X, Wong WS (2009). Current alternative and complementary therapies used in menopause. Gynecological Endocrinol, 25, 166-74.
DOI
|
6 |
Wu AH, Pike MC, Williams LD, et al (2007). Tamoxifen, soy, and lifestyle factors in asian american women with breast cancer. J Clin Oncol, 25, 3024-30.
DOI
|
7 |
Zhang Y-F, Kang H-B, Li B-L, Zhang R-M (2012). Positive effects of soy isoflavone food on survival of breast cancer patients in China. Asian Pac J Cancer Prev, 13, 479-82.
DOI
ScienceOn
|
8 |
Abdulkareem IH, Zurmi IB. (2012). Review of hormonal treatment of breast cancer. Nigerian J Clin Practice, 15, 9-14.
DOI
|
9 |
Albertazzi P, Pansini F, Bonaccorsi G, et al (1998). The effect of dietary soy supplementation on hot flushes. Obstetrics & Gynecology, 91, 6-11.
DOI
|
10 |
Antoine C, Liebens F, Carly B, Pastijn A, Rozenberg S (2007). Safety of alternative treatments for menopausal symptoms after breast cancer, A qualitative systematic review. Climacteric, 10, 23-26.
DOI
|
11 |
Bedell S, Nachtigall M, Naftolin F (2014). The pros and cons of plant estrogens for menopause. J Steroid Biochem Mol Biol., 139, 225-236.
DOI
|
12 |
Beral V, Banks E, Reeves G, Bull D (2003). Breast cancer and hormone-replacement therapy, The million women study. The Lancet, 362, 1330-1.
DOI
|
13 |
Biglia N, Cozzarella M, Cacciari F, et al (2003). Menopause after breast cancer, A survey on breast cancer survivors. Maturitas, 45, 29-38.
DOI
|
14 |
Boekhout AH, Beijnen JH, Schellens JH (2006). Symptoms and treatment in cancer therapy-induced early menopause. The oncologist, 11, 641-54.
DOI
|
15 |
Bruno D, Feeney KJ (2006). Management of postmenopausal symptoms in breast cancer survivors. Seminars in oncology, 33, 696-707.
DOI
|
16 |
Brzezinski A, Adlercreutz H, Shaoul R, et al (1997). Shortterm effects of phytoestrogen-rich diet on postmenopausal women. Menopause, 4, 89-94.
|
17 |
Burke GL, Legault C, Anthony M, Bland, et al (2003). Soy protein and isoflavone effects on vasomotor symptoms in peri-and postmenopausal women, The soy estrogen alternative study. Menopause, 10, 147-53.
DOI
|
18 |
Col NF, Hirota LK, Orr RK , et al (2001). Hormone replacement therapy after breast cancer, A systematic review and quantitative assessment of risk. J Clin Oncol, 19, 2357-63.
|
19 |
Caan BJ, Natarajan L, Parker B, et al (2011). Soy food consumption and breast cancer prognosis. Cancer Epidemiol Biomarkers Prev, 20, 854-8.
DOI
ScienceOn
|
20 |
Chen W-F, Huang M-H, Tzang C-H, Yang M, Wong M-S (2003). Inhibitory actions of genistein in human breast cancer (mcf-7) cells. Biochim Biophys Acta, 1638, 187-96.
DOI
|
21 |
Constantinou AI, White BE, Tonetti D, et al (2005). The soy isoflavone daidzein improves the capacity of tamoxifen to prevent mammary tumours. Eur J Cancer, 41, 647-54.
DOI
|
22 |
Davies C, Pan H, Godwin J, et al (2013). Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer, Atlas, a randomised trial. Lancet, 381, 805-16.
DOI
|
23 |
Davis VL, Jayo MJ, Ho A, et al ( 2008). Black cohosh increases metastatic mammary cancer in transgenic mice expressing c-erbb2. Cancer Res, 68, 8377-83.
DOI
|
24 |
Dorjgochoo T, Gu K, Zheng Y, et al (2011). Soy intake in association with menopausal symptoms during the first 6 and 36 months after breast cancer diagnosis. Breast Cancer Res Treat, 130, 879-89.
DOI
|
25 |
Eden JA.(2012). Phytoestrogens for menopausal symptoms, A review. Maturitas, 72, 157-9.
DOI
|
26 |
Fritz H, Seely D, Flower G, et al (2013). Soy, red clover, and isoflavones and breast cancer, A systematic review. PloS One, 8, 81968.
DOI
|
27 |
Handley AP, Williams M (2015). The efficacy and tolerability of ssri/snris in the treatment of vasomotor symptoms in menopausal women, A systematic review. J Am Assoc Nurse Practitioners, 27, 54-61
DOI
|
28 |
Gold EB, Flatt SW, Pierce JP, et al (2006). Dietary factors and vasomotor symptoms in breast cancer survivors, The WHEL study. Menopause, 13, 423-33.
DOI
|
29 |
Guha N, Kwan ML, Quesenberry Jr CP , et al (2009). Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors, The life after cancer epidemiology study. Breast Cancer Res Treat, 118, 395-405.
DOI
|
30 |
Hajirahimkhan A, Dietz BM, Bolton JL (2013). Botanical modulation of menopausal symptoms, Mechanisms of action? Planta Medica, 79, 538-53.
DOI
|
31 |
Ju YH, Doerge DR, Allred KF, Allred CD, Helferich WG (2002). Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (mcf-7) cells implanted in athymic mice. Cancer Res, 62, 2474-7.
|
32 |
Kang X, Zhang Q, Wang S, Huang X, Jin S (2010). Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy. Canadian Med Association J, 182, 1857-62.
DOI
ScienceOn
|
33 |
L'Esperance S, Frenette S, Dionne A, Dionne JY (2013). Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors, Cepo review and recommendations. Supportive Care Cancer, 21, 1461-74.
DOI
|
34 |
Levis S, Strickman-Stein N, Ganjei-Azar P , et al (2011). Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms, A randomized, double-blind trial. Arch Int Med, 171, 1363-9.
DOI
|
35 |
Mense SM, Hei TK, Ganju RK, Bhat HK (2008). Phytoestrogens and breast cancer prevention, possible mechanisms of action. Environment Hlth Perspect, 116, 426.
DOI
|
36 |
Liu B, Edgerton S, Yang X, et al (2005). Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention. Cancer Res, 65, 879-86.
|
37 |
Loprinzi CL, Barton DL, Rhodes D (2001). Management of hot flashes in breast-cancer survivors. Lancet Oncol, 2, 199-204.
DOI
|
38 |
MacGregor C, Canney P, Patterson G, McDonald R, Paul J (2005). A randomised double-blind controlled trial of oral soy supplements< i> versus placebo for treatment of menopausal symptoms in patients with early breast cancer. Eur J Cancer, 41, 708-14.
DOI
|
39 |
Murkies A, Lombard C, Strauss B , et al (1995). Dietary flour supplementation decreases post-menopausal hot flushes, Effect of soy and wheat. Maturitas, 21, 189-95.
DOI
|
40 |
Nechuta SJ, Caan BJ, Chen WY, et al (2012). Soy food intake after diagnosis of breast cancer and survival, An in-depth analysis of combined evidence from cohort studies of us and chinese women. Am J Clin Nutr, 96, 123-32.
DOI
|
41 |
Nikander E, Kilkkinen A, Metsa-Heikkila M, et al (2003). A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstets Gynecol, 101, 1213-20.
DOI
|
42 |
Pinkerton JV, Stovall DW, Kightlinger RS (2009). Advances in the treatment of menopausal symptoms. Women's health (London, England), 5, 361-384; quiz 383-364.
DOI
|
43 |
Pitkin J (2012). Alternative and complementary therapies for the menopause. Menopause Int, 18, 20-27.
|
44 |
Secreto G, Chiechi LM, Amadori A, et al (2004). Soy isoflavones and melatonin for the relief of climacteric symptoms, A multicenter, double-blind, randomized study. Maturitas, 47, 11-20.
DOI
|
45 |
Pruthi S, Qin R, Terstreip SA, et al (2012). A phase iii, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes, Ncctg n08c7. Menopause, 19, 48.
DOI
|
46 |
Quella SK, Loprinzi CL, Barton DL, et al (2000). Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors, A north central cancer treatment group trial. J Clin Oncol, 18, 1068-74.
|
47 |
Scambia G, Mango D, Signorile PG, et al (2000). Clinical effects of a standardized soy extract in postmenopausal women, A pilot study. Menopause, 7, 105-111.
DOI
|
48 |
Shu XO, Zheng Y, Cai H, et al (2009). Soy food intake and breast cancer survival. JAMA, 302, 2437-43.
DOI
|
49 |
St Germain A, Peterson CT, Robinson JG, Alekel DL (2001). Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause, 8, 17-26.
DOI
|
50 |
Taku K, Melby MK, Kronenberg F, Kurzer MS, Messina M (2012). Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity, Systematic review and meta-analysis of randomized controlled trials. Menopause, 19, 776-90.
DOI
|
51 |
Thomas A, Ismail R, Taylor-Swanson L, et al (2014). Effects of isoflavones and amino acid therapies for hot flashes and co-occurring symptoms during the menopausal transition and early post menopause, A systematic review. Maturitas. 78, 263-76.
DOI
|